美国FDA《血液行业指引:降低寨卡病毒输血传播风险的推荐意见》主要内容及其启示

发布时间：2018-05-07 02:13

本文选题：寨卡病毒 + 输血传播　；参考：《中国输血杂志》2016年02期

【摘要】：正为了紧急应对寨卡病毒(Zika virus,ZKV)经输血传播风险,日前美国FDA根据联邦法规相关规定的授权,紧急发布并立即实施了《血液行业指引——降低ZKV输血传播风险的推荐意见》(以下简称《指引》[1]。现将其主要内容介绍如下。1背景1.1概述ZKV属于黄病毒科的黄病毒属,主要通过埃及伊蚊,也可通过白纹伊蚊传播到人群[2-3]。此外,已有宫内、围产期和性传播的报告[4-6]。1947年从在乌干达寨卡原始
[Abstract]:An emergency response to the risk of blood transfusion-transmitted Zika virus Zika virus (Zika virus) came a day after the United States FDA was authorized under federal regulations. Emergency release and immediate implementation of the Blood Industry guidelines-recommendations to reduce the risk of ZKV transfusion transmission (hereinafter referred to as "guidelines" [1]). The main contents of this paper are as follows 1. 1 background 1.1: an overview of ZKV belonging to the yellow virus family, mainly through Aedes aegypti, but also through Aedes albopictus to the population [2-3]. In addition, there have been reports of intrauterine, perinatal and sexually transmitted infections [4-6].
【作者单位】：福建省血液中心;
【分类号】：R457.1

【相似文献】